Anti-KCNMB2 antibodies are used in the immunodetection of the protein potassium calcium-activated channel subfamily M regulatory beta subunit 2. In humans, the canonical protein has a reported length of 235 amino acid residues and a mass of 27.1 kDa. Its subcellular localization is in the membrane. It is reported to be expressed in the kidney, heart and brain. A member of the KCNMB (TC 8.A.14.1) protein family, KCNMB2 is a regulatory subunit of the calcium activated potassium KCNMA1 (maxiK) channel. Synonyms for this target antigen include BK channel beta subunit 2, BK channel subunit beta-2, MaxiK channel beta 2 subunit, MaxiK channel beta-subunit 2, and calcium-activated potassium channel subunit beta-2. KCNMB2 gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. A number of KCNMB2 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. In addition, ELISA is also a common application.